3628 results for «221»

Filter By

3628 results

Most impactful trials in structural heart disease 2024/2025

30 Sep 2025 – From PCR Gulf Valves 2025

Delve into the most impactful structural heart disease trials shaping 2024 and 2025. This session addresses current dilemmas in TAVI, including early intervention and management of small annuli, evaluates evidence for transcatheter mitral and tricuspid valve repair, and identifies evidence gaps relevant to the region, providing...

Most impactful trials in structural heart disease 2024/2025

Expanding horizons with balloon-expandable TAVI - LIVE Case

12 Sep 2025 – From PCR Rio Valves 2025

A 76-year-old male with a history of abdominal and iliac stent grafts (2022), severe COPD, prostate cancer, and gastric ulcer presented with symptomatic severe aortic stenosis. CT and echocardiography showed a calcified bicuspid aortic valve with preserved LV function.

A 24.5 mm Myval valve was implanted without...

Expanding horizons with balloon-expandable TAVI - LIVE Case

Stent failure - LIVE Case

11 Oct 2025 – From AICT-AsiaPCR 2025

This educational session presents a live case from Apollo Hospitals, Chennai, focusing on stent failure management. It emphasizes the critical role of imaging in optimizing treatment for in-stent restenosis, discusses essential lesion preparation tools, and reviews various therapeutic options to improve patient care.

 LIVE Educational Case from...

Stent failure - LIVE

SWISS-APERO: a randomized trial of the amulet versus watchman FLX devices for left atrial appendage closure

04 Nov 2021

The SWISS-APERO is a prospective, investigator-initiated, randomized, multi-center, and clinical trial designed to compare the Amulet and Watchman (2.5 and FLX) devices in a head-to-head fashion.

Francesco Costa

Author

Francesco Costa
SWISS-APERO: a randomized trial of the amulet versus watchman FLX devices for left atrial appendage closure

Post-TAVI cardiac arrest associated to acute coronary occlusion: facing the storm to gain calm

26 Jan 2024

Observe this TAVI case featuring pulseless electrical activity due to an unforeseen acute occlusion of the right coronary artery, and discover the strategies employed to address and resolve this critical complication.

Authors :

Juan Guzmán Olea, Gonzalo Tolosa Dzul, Beatriz Villegas González, Jonathan Uribe González,  Guillermo Arenas Fonseca, Tomás Herrera Arzola, Rosa Gutiérrez Castañeda, Víctor Sustaita Cerda, Raúl Cruz Palomera, Arely Méndez Mercado, Darío Valencia González, Carlos Javier González Álvarez, Héctor Hugo Escutia Cuevas, Daniel Iván Pérez Vásquez, Gabriel Guzmán Olea.Specialty Hospital, Puebla, IMSS, México
Post-TAVI cardiac arrest associated to acute coronary occlusion: facing the storm to gain calm

Mid-term echocardiographic outcomes following transapical mitral valve replacement: Updates from the Intrepid Pilot Study

19 Sep 2022

Pamela Gatto provides her take on the Intrepid Global Pilot Study which was presented by Renuka Jain at TCT Congress 2022.

Pamela Gatto

Author

Pamela Gatto
Updates from the Intrepid Pilot Study: Mid-term Echocardiographic Outcomes Following Transapical Mitral Valve Replacement

Five-year clinical and echocardiographic outcomes from the PARTNER 3 Low-Risk randomized trial

26 Oct 2023

Alex Sticchi provides his take on the 5-year outcomes from PARTNER 3 Low Risk which were presented by Martin B. Leon at TCT Congress 2023.

Alessandro Sticchi

Author

Alessandro Sticchi
Five-Year Clinical and Echocardiographic Outcomes from The PARTNER 3 Low-Risk Randomized Trial

PROSPECT II, COMBINE (OCT–FFR) and PROSPECT ABSORB: After revascularization of culprit lesions, assessment of coronary plaque size and composition matter!

17 Oct 2020

PROSPECT II, COMBINE (OCT–FFR) and PROSPECT ABSORB trials were presented at TCT Connect 2020. Hector Garcia-Garcia provides a summary of the key messages.

Author

Hector Garcia
Live from TCT Connect 2020: PROSPECT II, COMBINE (OCT–FFR) and PROSPECT ABSORB
Didn’t find what you were looking for?